The authors present a shift toward more integrated purification processes.
Hervé Broly
Advertisement
Hervé Broly is the head of biotech process sciences and the vice president at the Center of Expertise, Merck Serono SA
Articles by Hervé Broly
Apply a DoE strategy to test several formulations in parallel.
Combine cost analyses with QbD to improve operations and lower costs.
Advertisement
Latest Updated Articles
Safe Freeze–Thaw of Protein Drug Products: A QbD ApproachPublished: December 1st 2010 | Updated:
Cost of Goods Modeling and Quality by Design for Developing Cost-Effective ProcessesPublished: June 1st 2010 | Updated:
Intensification of a Chromatography PlatformPublished: July 1st 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
